BioCity Scotland appoints new board member
29 August 2012
BioCity Scotland, the centre for life science businesses in
Newhouse, Lanarkshire established earlier this year, has announced the
appointment of Dr Allison Jeynes-Ellis MB ChB, FFPM as a new Board
Formerly Medical and Innovation Director with the Association of the
British Pharmaceutical Industry, Dr Jeynes-Ellis will assume the
position in September 2012.
Dr Jeynes-Ellis has over twenty years industry experience as an
oncology specialist. Following an early career in the NHS, she had
medical positions with Ciba Pharmaceuticals, Bristol Myers Squibb
and Wyeth, UK and Ireland. In 2005 Dr Jeynes-Ellis became an
independent pharmaceutical consultant before moving to the ABPI in
2009. She subsequently returned to consulting.
a Board member, Dr Jeynes-Ellis will support Chairman Dr Louis J
Nisbet and recently-appointed Managing Director Fraser Black in
bringing bioscience and life sciences companies to the 9 ha site.
BioCity Scotland has already welcomed seven companies to
the site and has the support of six commercial partners including
lawyers, accountants and intellectual property advisers. A variety
of visitors has already passed through the busy campus including HRH
The Princess Royal, international business delegations, and local
school students eager to learn more about a career in science.
Commenting on her appointment Dr Jeynes-Ellis said, I am
delighted to be part of this exciting opportunity for Scotland, as I
strongly believe that BioCity Scotland can be instrumental in
driving Scotland’s continued success and further growth within the
life science sector.
Dr Louis Nisbet, BioCity Scotland Chairman added, "We are
delighted to welcome Allison to the Board of BCS. Her extensive
experience with the pharmaceutical and biotechnology industries,
coupled with her government and NHS relationships will be immensely
valuable. With this she brings personal drive and great enthusiasm
for building new life sciences companies in Scotland"
The existing BioCity Scotland board members are Dr Louis J.
Nisbet (Chairman); Dr Glenn Crocker, CEO BioCity Group; Malcolm
Bateman, CEO Roslin BioCentre; Ian Webster and Fraser Black,
Managing Director BioCity Scotland.